MECOM: a Bioinformatics and Experimentally Identified Marker for the Diagnosis and Prognosis of Lung Adenocarcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

MECOM: a Bioinformatics and Experimentally Identified Marker for the Diagnosis and Prognosis of Lung Adenocarcinoma

Published:2024-01 Issue:2 Volume:18 Page:79-91
ISSN:1752-0363
Container-title:Biomarkers in Medicine
language:en
Short-container-title:Biomark. Med.

Author:

Li Anqi¹^ORCID,Li Meng¹,Wang Jing²,Zhou Jiejun¹,Yang Tian¹,Fan Meng¹,Zhang Kun¹,Gao Hengxing¹,Ren Hui¹,Chen Mingwei¹²^ORCID

Affiliation:

1. Department of Respiratory & Critical Care Medicine, First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, 710061, China

2. Department of Pulmonary & Critical Care Medicine, Shaanxi Provincial Second People’s Hospital, Xi’an, 710005, China

Funder

Natural Science Foundation of Shaanxi Province

WuJieping Foundation

Key Research and Development Projects of Shaanxi Province

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.2217/bmm-2023-0600

Reference48 articles.

1. Cancer statistics, 2017

2. The biology and management of non-small cell lung cancer

3. Cancer statistics in China, 2015

4. Lung Cancer in People’s Republic of China

5. Lung Cancer 2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP